Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population

Background: Diabetes is an immunocompromising condition, and diabetic children should receive the 23-valent pneumococcal polysaccharide (PPSV23) vaccine as part of their preventive care because of their increased risk for invasive pneumococcal disease. This recommendation is often not followed, howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirza, Aymen, Jagadish, Apoorva, Trimble, Kelsey, Olanrewaju, Adijat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Division of Ochsner Clinic Foundation 2022
Materias:
Quality Improvement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477126/
https://www.ncbi.nlm.nih.gov/pubmed/36189088
http://dx.doi.org/10.31486/toj.22.0036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477126/
https://www.ncbi.nlm.nih.gov/pubmed/36189088
http://dx.doi.org/10.31486/toj.22.0036

Ejemplares similares